"10.1371_journal.pone.0056134","plos one","2013-02-13T00:00:00Z","Xinqi Wu; Melina E Marmarelis; F Stephen Hodi","Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, United States of America; Melanoma Disease Center, Dana-Farber/Brigham and Womenâ€™s Cancer Center, Boston, Massachusetts, United States of America; Harvard Medical School, Boston, Massachusetts, United States of America","Conceived and designed the experiments: XW MEM FSH. Performed the experiments: XW MEM. Analyzed the data: XW MEM FSH. Wrote the paper: XW MEM FSH.","The authors have the following interests. F.S.H. has served as a non-paid consultant to Synta Pharmaceuticals and received clinical trial support from Synta Pharmaceuticals. Ganetespib used in this study was provided by Synta Pharmaceuticals Corp. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2013","02","Xinqi Wu","XW",3,TRUE,3,2,3,3,TRUE,TRUE,FALSE,0,NA,FALSE
